Unknown OBSERVATIONAL NCT04927676

Hormones in Hypogonadotropic Hypogonadism

Hormone Profile in Women With Hypogonadotropic Hypogonadism - a Prospective Pilot Study

Sponsor: Ferring Arzneimittel GmbH

Conditions AMH Follicle Cyst Hypogonadism, Hypogonadotropic

Updated 8 times since 2021 Last updated: Oct 19, 2023 Started: Apr 2, 2023 Primary completion: Jun 30, 2024 Completion: Aug 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04927676, this observational or N/A phase trial focuses on AMH and Follicle Cyst and remains ongoing. Sponsored by Ferring Arzneimittel GmbH, it has been updated 8 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Dec 2025 — Present [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2024 — Dec 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Nov 2023 — Jul 2024 [monthly]

Recruiting

Status: Unknown Status → Recruiting
Oct 2023 — Nov 2023 [monthly]

Unknown Status

Status: Not Yet Recruiting → Unknown Status

▶ Show 3 earlier versions

Dec 2021 — Oct 2023 [monthly]

Not Yet Recruiting
Oct 2021 — Dec 2021 [monthly]

Not Yet Recruiting
Sep 2021 — Oct 2021 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ferring Arzneimittel GmbH
Medical University of Vienna

Data source: Medical University of Vienna

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vienna, Austria